FindMyKOL
Clinical trialNCT00999713CompletedPhase 2/PHASE3Interventional

CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients

SponsorMilton S. Hershey Medical CenterEnrollment43Acute Lung Injury
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Acute lung injury (ALI) is a common, life-threatening complication among pediatric leukemia and lymphoma and hematopoietic stem cell transplant (HSCT) recipients. Although these children represent a relatively small and unique patient population, they account for the largest proportion of deaths of all pediatric diseases. The long-term goal of this project is to improve outcomes among these patients. Recently, the intratracheal administration of calfactant has resulted in decreased mortality among children with ALI including promising results among children with cancer and following HSCT. Consequently, the primary specific aim of this study is to assess the effect of calfactant on intensive care (PICU) survival among pediatric leukemia and lymphoma and HSCT patients with ALI. Secondary aims include assessment of the effect of calfactant on oxygenation and on the length of mechanical ventilation, PICU stay, and hospital stay. Calfactant therapy has been found to be of benefit in acute lung injury in the overall pediatric population by improving oxygenation and decreasing mortality. These findings, in conjunction with recent subgroup analysis in which calfactant therapy appeared to improve outcomes in immunocompromised children provide the rationale for assessing calfactant therapy in this patient population. Funding Source - FDA Office of Orphan Products Development (OOPD)

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Neal J Thomas, MD, MSc

    Penn State College of Medicine, Penn State Milton S. Hershey Medical Center

    Principal Investigator
  • Robert F Tamburro, MD, MSc

    Penn State College of Medicine, Penn State Milton S. Hershey Medical Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Hospital Sainte Justine

    Montreal, Quebec, Canada

United States
  • Phoenix Children'S Hospital

    Phoenix, Arizona, United States

  • Children'S Hospital of Los Angeles

    Los Angeles, California, United States

  • University of California San Francisco

    San Francisco, California, United States

  • Riley Children'S Hospital

    Indianapolis, Indiana, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • Weill Cornell Medical Center

    New York, New York, United States

  • Maria Fareri Children'S Hospital

    Valhalla, New York, United States

  • Rainbow Babies Hospital

    Cleveland, Ohio, United States

  • Nationwide Children'S Hospital

    Columbus, Ohio, United States

  • Penn State College of Medicine, Penn State Milton S. Hershey Medical Center

    Hershey, Pennsylvania, United States

  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

  • Children'S Hospital of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • St. Jude Children'S Research Hospital

    Memphis, Tennessee, United States

  • Texas Children'S Hospital

    Houston, Texas, United States

  • Children'S Hospital of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Calfactant
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2010
Primary completion
30 Sept 2015
Completion
31 Oct 2015
Last update posted
16 Mar 2018
Registered enrollment
43
Registry id
NCT00999713

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.